Skip to main content
Bicara Therapeutics CMO on Muck Rack

Bicara Therapeutics CMO

As seen in: Investing.com UK
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Bicara Therapeutics

Contact Bicara Therapeutics, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

David Raben, Bicara Therapeutics CMO, sells $405k in BCAX stock

|
By David Raben, Bicara Therapeutics CMO
| Investing.com UK
Chief Medical Officer of (NASDAQ:BCAX), David Raben, sold 22,000 shares of common stock at a price of $18.45 on October 9, 2025, for a total of $405,900. The sale comes as the stock shows strong momentum, with a 75% gain over the past six months, though InvestingPro analysis indicates the stock is currently in overbought territory.
Open in Who Shared Issue with article?
See all 1 articles